some info in the Cannabinoid space........our time will come and definitely not 11% but more like 1111% on one product alone
ASX Health Stocks: Partnership deals send Avecho shares flying this morning - * or St0ckh3adAvecho Biotech (ASX:AVE) surged by 11% on an expanded collaboration deal with theLambert Initiative, a leading Australian academic centre for the discovery of cannabinoid (CBD) therapeutics.
Under the new deal, Avecho will provide its CBD soft-gel capsule to the Lambert Initiative for use in two further clinical trials.
These new trials will examine potential new indications that may be treatable using lower doses of CBD.
Avecho has previously collaborated with Lambert on a successful Phase 2 clinical trial on the use of a topical CBD TPM gel for the treatment of osteoarthritis of the fingers and hands.
Results from this study were presented by Lambert researchers at the International Cannabinoid Research Society Symposium on the Cannabinoids in June last year.
A larger topical CBD trial is currently being planned with Lambert in 2023, as is a further study that will examine a topical cannabigerol (CBG) TPM product.
“Lambert Initiative’s decision to use Avecho’s CBD product in their own studies is testament to the clinical relevance of the work we’ve conducted over the last three years on product development in the cannabinoid space,” said Avecho CEO, Paul Gavin.
